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Introduction
During treatment and follow up of patients with diabetes mellitus (DM), hyperglycemia has for long been an undesirable element. Polyuria, polyphagia and polydipsia, three cardinal symptoms induced by hyperglycemia, have always blurred signs of insulin absence, such as enhanced muscle destruction and lower utilization of glucose by myocytes. Muscle destruction might induce loss of weight, which can normally be observed in type I diabetic patients, since insulin is a key factor for muscle eutrophy maintenance [1] . Moreover, the absence of insulin itself may change other physiologic cell pathways. The internalization of glucose transporters [2] , abrogating the availability of glucose intracellularly, is just one of the alterations in cell metabolism induced by lack of insulin. Recently, type I diabetes mellitus (DMI) has been associated to autophagy-lysosome pathway (ALP) dysfunction, which among other defects, contributes for pancreatic β cells destruction [3] . Important for cell and tissue homeostasis maintenance, ALP dysfunction has also been associated to other disorders, such as Alzheimer [4] , cancer and autoimmunity [5] . Moreover, autophagy has also been associated to microbial resistance. It has been suggested that some pathogens escape host defense, highjack the autophagy pathway and may establish a persistent infection [6] . Infection is of particular concern for DM patients and according to the American Diabetes Association (ADA) website, individuals with diabetes have three times higher risk of dying from flu or pneumonia since they are more susceptible to secondary infections [7] . Styes, folliculitis and other skin complications are also more common in people with diabetes. Experiments using Komeda diabetes-prone (KDP) rats infected with Mycobacterium tuberculosis (Mt), have shown that the burden of the bacilli observed in lungs and spleens of rats was more common when compared to healthy controls. In infected KDP rats, bacteremia impaired the production of nitric oxide (NO) by alveolar macrophages (AM) [8] that constitute an important entry barrier. Studies in alloxan-induced diabetic rats have also shown impairment in peripheral blood leukocyte phagocytic activities [9, 10] . Using the same model, it was published that diabetic AM have impaired phagocytosis [11] . In patients, diabetic neutrophils have shown dysfunction on their chemotactic and phagocytic abilities [12] and some of these alterations are reversible after insulin treatment [13] . How autophagy and phagocytosis are associated to each other is uncertain. Upon infection, AM from mice lacking autophagy gene 7 (Atg 7 -/-) sheltered higher amount of Mycobacterium bovis bacillus Calmette-Guerin (BCG) and Mt compared to normal mice. [14] . After autophagy induction, macrophages phagocyted more BCG, although showing lower survival [15] .
In this work, using a well established rat model for type I diabetes, we would like to investigate if there is any difference on autophagy phenotype in macrophages derived from bone marrow, BAL fluid and spleens in diabetic rats. Furthermore, verify if there is any influence of insulin treatment upon autophagy pathway.
Material and Methods
for the Control of Animal Experimentation (CONCEA) and approved by the Ethical Committee on Animal Use (CEUA) of the Faculty of Pharmaceutical Sciences (FCF) and Medical School (FM), University of São Paulo, before initiating the experiments.
Animals were divided in three groups: control (C), diabetic (D) and diabetic rats treated with insulin (DI) and followed protocol published previously [16] . Briefly, diabetes mellitus was induced by the intravenous injection of 42mg/kg of alloxan (ALX) (Sigma Chemical Co, St Louis, Mo) dissolved in physiological saline (0,9% NaCl). Control rats were injected with physiological saline alone. Ten days after diabetes induction, peripheral blood glucose (from the rat tail) was determined using blood glucose monitor Accu-Chek Advantage II (Roche Diagnostica, Sao Paulo, SP, Brazil). Animals were considered diabetic if glucose was above 200 mg/dL. Insulin treated group, received 4 IU of neutral protamine Hagedorn insulin (Eli Lilly, São Paulo Brazil.) s.c., 8 hours before the experiment and other groups received saline solution.
Bronchoalveolar lavage
Animals were anesthetized by an intraperitoneal injection of ketamine hydrochloride 90 mg/ kg (Ceva Santé Animale, Paulínia-SP, Brazil) and xylazine hydrochloride (Ceva Santé Animale, Paulínia-SP, Brazil) 10mg/kg. After being anesthetized, trachea was exposed through a midline ventral incision of approximately 0.5 cm length in the neck. Bronchoalveolar lavage (BAL) was performed by instillation of 10 mL of PBS, at room temperature, through a polyethylene tube (1 mm in diameter) inserted into the trachea, as published previously [16] . First 10 mL instilled into the lungs was withdrawn and reinjected twice. After centrifugation (500g for 10 min), the supernatant was kept at -70 o C until cytokine measurements. The lungs were further lavaged with 15 mL PBS (3 x 5 mL) to obtain remaining leukocytes. The BAL fluid was not used if the retrieved volume was less than 85% of the 25 mL instilled [16] .
Enzyme immunoassay for cytokines and chemokines
The concentrations of tumor necrosis factor (TNF)-α, interferon (INF)-γ, cytokine-induced neutrophil chemoattractant 1 (CINC-1) and CINC-2, interleukin (IL)-1β, IL-10 and IL-6 in the BAL supernatant were determined by enzyme-linked immunosorbent assay (ELISA) using commercially available kits according to the manufacturer's instructions (R&D Systems Inc, Minneapolis, USA). The sensitivity of the assay was 15 pg/mL [16] .
Bone Marrow derived Macrophages
Bone marrow macrophages (BMM) were generated as published previously [17] [18] [19] . In summary, femur and tibia from rats were flushed with RPMI 1640 medium, centrifuged and resuspended (10 6 cells/ml) in RPMI, enriched with 10% heat-inactivated fetal calf serum (FCS) either with rat recombinant macrophage colony-stimulating factor (M-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) (both from Peprotech, Princeton, NJ, USA). On the 4 rd day of incubation in 5% CO 2, 37 o C, nonadherent cells (BMM precursors) were collected and further incubated for 3 days with fresh medium enriched with the same growth factor (same as above). On day 7, adherent cells from the plates were harvested by vigorous pipetting and used for experiments. Some of the cultures were also performed on the top of coverslips (for microscopy).
Histology and flow cytometry
Spleens were either fixed in formaldehyde or snap frozen in Tissue-Tek OCT (Sakura, Torrance, CA, USA). Sections (8-10 μm) were cut, air dried overnight and those not fixed with formaldehyde were fixed in cold acetone. Immunohistochemistry was performed as previously published [20] . Images were acquired using a Leica confocal laser scanning microscope (Leica Microsystems, GmBH, Wetzlar, Germany) equipped with 1 argon and 2 HeNe lasers, using magnification lens at 20×/0.70 CS and 63×/1.32 immersion oil and 90% glycerol (MP Biomedicals). The pictures are representative of at least 3 analysed spleen sections per rat and for BAL, triplicates from the same sample was performed. To quantify fluorescence, Integrated Density was determined by Fiji (Image J, NIH, USA). For flow cytometry analysis, single cell suspensions from BAL, BMM and spleens were prepared and erythrocytes lysed. Cells were immunolabelled and acquired using LSR Fortessa (Becton, Dickinson and Company, NJ, USA). Analyses were made using FlowJo software (version X.0 TreeStar Inc.) [20] .
Results

Higher expression of LC3 in macrophages from bronchoalveolar lavage in diabetic rats treated with insulin
Consistently with previous studies [16] , ALX treated rats showed typical DMI signs, including elevated blood glucose and lower rate of weight gain (data not shown). LC3 is a soluble protein ubiquitously distributed in mammalian cells and tissues. Using a validated flow cytometry technique that excludes cytoplasmic form of LC3, we examined macrophages from BAL and screened for their LC3 autophagosomal membrane bound content (Fig. 1D) . While AM from both control and diabetic rats did not show LC3 expression differences, AM from diabetic animals treated with insulin showed 5 fold enhanced LC3 autophagosomal membrane bound expression (Fig. 1D) . Confocal studies were also performed ( Fig. 2) and analysis of BAL cells integrated density showed higher accumulation of LC3 on cells derived from diabetic animal treated with insulin ( Fig. 2 A) . Cytokines from BAL were determined but only CINC-1 (Fig. 3A) and CINC-2 ( Fig. 3B ) expressions were detected. Interestingly, 
Distinct phenotypes in bone marrow derived macrophages from control and diabetic rats
To determine if environment can modulate LC 3 uptake in AM precursor cells, two lineages of macrophages called as M1 and M2 macrophage-like were generated from bone marrow progenitors. Bone marrow progenitor cells from control, diabetic and diabetic rats treated with insulin were isolated and cultured in RPMI with normal glucose concentration media. To assess activation of the autophagy pathway we determined the LC3 autophagosome bound content by flow cytometry. After one week in culture, M1-like macrophages from diabetic and diabetic rats treated with insulin showed lower LC3 contents, compared to control animals (Fig. 4D) . Conversely, M2-like macrophages from both diabetic groups 
Diabetic Macrophages in spleen showed lower levels of autophagy
Spleens from control, diabetic and diabetic animals treated with insulin were examined for autophagy activation using Atg 12 (Fig. 6) . When integrated density of red and white pulp was compared, macrophages showed higher autophagic content compared to other leucocytes (Fig. 6) . After diabetic rats were treated with insulin, autophagy related marker did not recover basal levels (Fig. 6 G, H) .
Discussion
Data presented herein suggest that expression of the LC3 bound to autophagosomes, varies depending on the type of macrophage. Insulin seems to influence in multifaceted ways macrophages from distinct origins. In ALX induced diabetes in rats, hyperglycemia and absence of insulin did not change autophagosome LC 3 levels in BAL. When bone marrow cells were differentiated into M1-like macrophages, those cells derived from diabetic animals have lowered their autophagosome LC3 content. Conversely, cells differentiated into M2-like macrophages, have their autophagic LC3 content enhanced. When one of the proteins (Atg12) responsible for conjugating LC3 into the phagosome was screened, it was diminished in the splenic macrophages (SM) from red pulp of the diabetic animals, compared to healthy control. When diabetic rats were treated with insulin, SM failed to restore Atg 12 content. 6 . Spleen autophagy levels: Spleens from normal, diabetic and insulin treated rats were frozen in OCT and sectioned. Confocal microscopy showing spleen histology (with follicles) in A, B, C (bar=400μm magnification 20x) and red pulp macrophages in D,E,F (bar= 25μm magnification 63x zoom 1) from control (A,D), diabetic (B,E) and insulin treated (C,F) rats. Data presented as RGB pictures (red is KiM2R macrophage marker, green is LC3, and blue is CD45 Integrated density from Atg 12 content in spleen (G) red and (H) white pulp (*p< 0.05; ** p< 0.001) was measured. Sunahara 
Higher prevalence of infection contributes to an elevated mortality in diabetic patients [21, 22] . Many mechanisms can relate predisposition to infection in diabetes and dysfunction of the innate immunity is considered one of the major explanations [23] . Important for antigen processing, AM are responsible for respiratory infections associated to DMI [11, 24] . Most of the experimental literature has suggested that phagocytosis in macrophages and antigen presentation to T cells is impaired [11, 25] . The autophagy pathway has been less studied in diabetic macrophages. Being important to maintain homeostasis, autophagy pathway imbalance in macrophages has been associated to non-infectious [26, 27] and infectious [5, 28] diseases. Manipulation of defects in autophagic signalling has been shown to attenuate glomerular damage [29] and ameliorate cardiac injury in mice [30] . Since insulin is a modulator of the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) pathway [5] , DMI is a natural model for autophagy pathway imbalance. Here, with the ALX induced rat model, we studied autophagy markers in different sources of macrophages from a non-infectious perspective.
Previous studies of our group have suggested that using this animal model, AM showed impaired phagocytosis [11] and the treatment with insulin restored their function. Also, some inflammatory parameters such as cytokines expression (IL-6, CINC-1 and CINC-2) were restored by insulin [13] . Since phagocytic pathway also requires LC3 recruitment, we have chosen to study the LC3 expression in these cells. LC3 as shown recently, counteracts in both processes: phagocytosis [31] and autophagy [31, 32] . It has been also demonstrated that LC3 can be recruited to the phagosome, constituted by a single membrane in a process named LC3 associated phagocytosis (LAP) [33] . LAP is a process distinct from autophagy and is always related to pathogen engulfment. During autophagy, a lipidated form of the LC3, required for membrane elongation, is not necessarily dependent on the presence of a pathogen. Autophagy is a continuous process needed for turnover of proteins and organelles [5] . There are many LC3 isoforms and the autophagy hallmark indicator is the lipidated membrane-bound form LC3II [32] . Most of previous studies have used Western blotting to determine levels of LC3II expression. Unfortunately this method is not the best to use, since BAL is constituted by an assortment of cells. Recently, the Autophagy journal has accepted the use of LC3 II as an autophagy marker [34] . Therefore, we used a flow cytometry protocol for autophagy [35] and combined the usage of LC3B with markers for macrophages. Our results showed that LC3 protein is less expressed on AM vesicles from diabetic rats compared to those treated with insulin. Intriguingly, levels of LC3 from diabetic AM were the same as found in control rats. It was not possible to affirm if diabetic AM fail to upregulate autophagy or the absence of insulin and associated hyperglycemia induce AM to protect the host by not enhancing the autophagy as a beneficial adaptive process [30] . When insulin was added to the system, AM started to enhance LC3 content. Despite not having developed functional assays, this result suggested that AM are not impaired, they are able to perform autophagy, but they refrain themselves probably, as inferred previously, to self protecting. A recent published review about autophagy in skeletal muscle suggested that in glycogen storage diseases, the accumulation of autophagosomes along the myofibers indicated a pathologic phenotype [36] and this is in accordance to previous phenomena observed in cardiomyocytes.
Spleen macrophages and cells from white pulp of the diabetic rats showed lower Atg 12 protein expression. When insulin was administrated, these cells did not restore previous levels of Atg 12. It is intriguing because insulin was capable of restoring AM phagocytosis [11] . Why insulin enhanced LC3 levels in AM but not in SM remains unclear. However, if AM have their phagocytic function restored by insulin and are capable of increasing LC3 levels, maybe AM have not impaired function. Up to date, it is not known whether there is a hierarchy relating triggering stimulus and AM response. Also, all macrophages types were not screened and certainly one type of macrophage may suffer from the absence of insulin more than the others. What we would like to highlight here is that there might exist a signaling hierarchy that was not fully understood. During inflammation, in diabetic hosts, when insulin cannot exert its function, some immune cells may have a shut down system to protect the host. However, the protection turns against the organism, if sustained for long [37] . Probably, this amount of energy cannot be lost for performing autophagy when there is a lack of insulin, and difficulty in bringing glucose from the outside to the inner part of the cell. Therefore, immune cells may fail to enhance turn over of self-damaged organelles in order to save energy. Low autophagy levels in diabetic AM are in accordance with the concomitant diminished phagocytosis, since phagocytosis and autophagy although different, are related pathways. Regarding BMM, hyperglycemia and insulin absence acts antagonistically in M1 and M2 macrophages. Pro inflammatory M1 macrophages had their LC3 content decreased in the absence of insulin, while M2 macrophages exhibited higher amount of LC3. M1 and M2 nomenclature was adopted in analogy to Th1 and Th2 T cell responses. As Sica and Mantovani described [38] , the better understanding of the polarization M1-M2 provides knowledge for macrophage-centered diagnosis, helping to develop treatment based on innate immunity as a target.
Since autophagy is related to the origin of energy production and expenditure, a better understanding of the whole pathway is required. We strongly believe that discovering an alternative to manipulate the autophagy pathway in favor of diabetic patients, it will be possible to control many of the infections since it might recover phagocytic function although functional assays should be performed in diabetic patients.
